199 related articles for article (PubMed ID: 16453254)
21. [Clozapine-associated neuroleptic malignant syndrome followed by catatonia: a case report].
Erol A; Putgül G; Sert E; Mete L
Turk Psikiyatri Derg; 2013; 24(2):140-4. PubMed ID: 23754268
[TBL] [Abstract][Full Text] [Related]
22. Marked elevation of serum creatine kinase associated with olanzapine therapy.
Marcus EL; Vass A; Zislin J
Ann Pharmacother; 1999 Jun; 33(6):697-700. PubMed ID: 10410183
[TBL] [Abstract][Full Text] [Related]
23. Thrombocytopenia secondary to the use of quetiapine.
Handoo I; Perales M; Klaus N; Khan AY
J Child Adolesc Psychopharmacol; 2010 Oct; 20(5):453-5. PubMed ID: 20973718
[No Abstract] [Full Text] [Related]
24. [Edema related to treatment with olanzapine].
Wustmann T; Fiedler T; Gutmann P
Psychiatr Prax; 2009 Apr; 36(3):142-4. PubMed ID: 18504690
[TBL] [Abstract][Full Text] [Related]
25. Risperidone-induced marked elevation of serum creatine kinase in adolescence. A case report.
Holtmann M; Meyer AE; Pitzer M; Schmidt MH
Pharmacopsychiatry; 2003 Nov; 36(6):317-8. PubMed ID: 14663658
[TBL] [Abstract][Full Text] [Related]
26. Discontinuation of quetiapine from an NIMH-funded trial due to serious adverse events.
Jeste DV; Jin H; Golshan S; Mudaliar S; Glorioso D; Fellows I; Kraemer H; Arndt S
Am J Psychiatry; 2009 Aug; 166(8):937-8. PubMed ID: 19651757
[No Abstract] [Full Text] [Related]
27. Effect of topiramate on plasma concentrations of clozapine, olanzapine, risperidone, and quetiapine in patients with psychotic disorders.
Migliardi G; D'Arrigo C; Santoro V; Bruno A; Cortese L; Campolo D; Cacciola M; Spina E
Clin Neuropharmacol; 2007; 30(2):107-13. PubMed ID: 17414943
[TBL] [Abstract][Full Text] [Related]
28. Antipsychotic-associated weight gain.
Gentile S
Ann Pharmacother; 2004 May; 38(5):903-4. PubMed ID: 14996995
[No Abstract] [Full Text] [Related]
29. Tardive dyskinesia in older patients.
Jeste DV
J Clin Psychiatry; 2000; 61 Suppl 4():27-32. PubMed ID: 10739328
[TBL] [Abstract][Full Text] [Related]
30. Massive asymptomatic creatine kinase elevation in youth during antipsychotic drug treatment: case reports and critical review of the literature.
Masi G; Milone A; Viglione V; Mancini A; Pisano S
J Child Adolesc Psychopharmacol; 2014 Dec; 24(10):536-42. PubMed ID: 25387323
[TBL] [Abstract][Full Text] [Related]
31. Granulocytopenia with clozapine and quetiapine.
Diaz P; Hogan TP
Am J Psychiatry; 2001 Apr; 158(4):651. PubMed ID: 11282709
[No Abstract] [Full Text] [Related]
32. Neuroleptic malignant syndrome with use of quetiapine in mental retardation.
Dan A; Bharadwaj R; Grover S
Psychiatry Clin Neurosci; 2009 Apr; 63(2):255-6. PubMed ID: 19335404
[No Abstract] [Full Text] [Related]
33. Severe hyperlipidemia associated with olanzapine and quetiapine use.
Carnahan RM; Reantaso AA; Teegarden BA; Pogue T
Am J Psychiatry; 2007 Oct; 164(10):1614-5. PubMed ID: 17898359
[No Abstract] [Full Text] [Related]
34. FDA panel issues mixed decision on quetiapine in depression and anxiety.
Kuehn BM
JAMA; 2009 May; 301(20):2081-2. PubMed ID: 19470978
[No Abstract] [Full Text] [Related]
35. Quetiapine-induced neuroleptic malignant syndrome in dementia with Lewy bodies: a case report.
Kobayashi A; Kawanishi C; Matsumura T; Kato D; Furukawa R; Kishida I; Hirayasu Y
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1170-2. PubMed ID: 16682107
[TBL] [Abstract][Full Text] [Related]
36. [Psychotic symptoms in a case of locked-in syndrome].
Mutschler J; Czell D; Kaps M; Manzl G
Nervenarzt; 2006 Dec; 77(12):1483-6. PubMed ID: 17106731
[TBL] [Abstract][Full Text] [Related]
37. No recurrence of a neuroleptic malignant syndrome under quetiapine.
Brieger P; Reinelt Y
Aust N Z J Psychiatry; 2003 Oct; 37(5):627. PubMed ID: 14511095
[No Abstract] [Full Text] [Related]
38. Two new atypical antipsychotics: advantages and disadvantages.
Lemon MD
S D J Med; 1998 Aug; 51(8):285-6. PubMed ID: 9724957
[No Abstract] [Full Text] [Related]
39. All elevated creatine kinase is not neuroleptic malignant syndrome.
Maniam T; Rahman MA
Med J Malaysia; 1994 Sep; 49(3):252-4. PubMed ID: 7845275
[TBL] [Abstract][Full Text] [Related]
40. Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia.
Sernyak MJ; Leslie DL; Alarcon RD; Losonczy MF; Rosenheck R
Am J Psychiatry; 2002 Apr; 159(4):561-6. PubMed ID: 11925293
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
